-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TMSBTO8GpOzc40JwIaj5yMOWCkafmTf9WyAXsNQZdjcpCTn/XY1VqokfbmdUrsLi JaqgrrsCa1WmWB+O1gYvGA== 0001104659-03-013948.txt : 20030703 0001104659-03-013948.hdr.sgml : 20030703 20030702190250 ACCESSION NUMBER: 0001104659-03-013948 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030630 FILED AS OF DATE: 20030703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CONRAD HERBERT J CENTRAL INDEX KEY: 0001218815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 03773386 MAIL ADDRESS: STREET 1: 134 LOWELL RD CITY: GLEN ROCK STATE: NJ ZIP: 07452 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 4 1 j2776_4.xml 4 X0101 4 2003-06-30 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218815 CONRAD HERBERT J 1 0 0 0 Common Stock, $.01 par value per share 2003-06-30 4 A 0 535 4.67 A 10052 D Options to purchase Common Stock, $.01 par value per share 4.67 2003-06-30 4 A 0 5000 0 A 2004-06-30 2013-06-30 Common Stock, $.01 par value per share 5000 5000 D These shares were granted pursuant to the Company's Stock Compensation Plan for Outside Directors, which provides for the grant to non-employee directors of that number of shares of Common Stock having an aggregate fair market value on the last business day of each quarter equal to $2,500, until he is no longer an Outside Director. On June 30, 2003, the fair market value of the Common Stock, based on the closing price, was $4.67. /s/ Herbert Conrad 2003-07-02 -----END PRIVACY-ENHANCED MESSAGE-----